Treatment-related signs and symptoms among patients with urea cycle disorders (UCDs) during treatment with sodium phenylbutyrate and glycerol phenylbutyrate
Sandesh C.S. Nagamani(Baylor College of Medicine), Brendan H. Lee(Baylor College of Medicine), Andreas Schulze(University of Toronto), George A. Díaz(Icahn School of Medicine at Mount Sinai), Dion F. Coakley, Mark Korson(Tufts Medical Center), Sue A. Berry(University of Minnesota), Wendy E. Smith(Maine Medical Center), Bruce F. Scharschmidt, Cindy Le Mons(National Urea Cycle Disorders Foundation), Masoud Mokhtarani, Uta Lichter‐Konecki(Children's National), Nicola Longo(Center for Human Genetics), Dennis W. Bartholomew(Nationwide Children's Hospital), Annette Feigenbaum(Hospital for Sick Children), Shawn E. McCandless(University Hospitals of Cleveland), William E. Berquist(Lucile Packard Children's Hospital), Robert Zori(University of Florida), David Kronn(New York Medical College), James Bartley(MemorialCare Long Beach Medical Center), William J. Rhead(Children's Hospital of Wisconsin), Renata C. Gallagher(Children's Hospital Colorado), Cary O. Harding(Oregon Health & Science University)
Cited by 0
Related Papers
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
|Genetics in Medicine|2014|718
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
|Genetics in Medicine|2017|563
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine
|npj Genomic Medicine|2016|377